Hywin And FactSet Launch Healthcare Index

Amanda Cheesley

1 July 2022

, a global provider of integrated financial information and analytics, have launched FactSet Hywin Global Health Care Index to enable global investors to capture investment opportunities in the healthcare industry.

Calculated using FactSet’s proprietary datasets, the index tracks 40 company stocks selected from 19 stock exchanges, covering 36 sub-sectors of healthcare, the firm said. The companies include Thermo Fisher, Johnson & Johnson, Pfizer, and global healthcare firms; each stock has a market capitalisation of more than $1 billion and daily liquidity of over $5 million. With a maximum of 5 per cent single-stock weighting, the firm said that the index represents a benchmark for the global healthcare industry.

As a barometer of the healthcare sector, the index serves as a new reference for fund managers who invest in the industry and provides a valuable prism for analysts and investors, the firm added.

“Healthcare has never been more important. Whether it’s facing an ageing society, meeting emerging medical challenges, or identifying new solutions related to pandemic mitigation, this industry sits at the crux of what is most important to global investors and business leaders alike,” said Wang Dian, chief executive officer of Hywin Holdings.

“FactSet is pleased to collaborate with Hywin on this initiative to help investors appreciate the economic logic and technical merits of passive investing, trend participation, and optimised diversification within the healthcare sector,” Jeremy Zhou, vice president, head of index solutions at FactSet added.

“As global investors continue to allocate their wealth across more sectors and thematics, index-based solutions will become crucial building blocks of their investing process,” he said.

FactSet Hywin Global Health Care Index, which will be published daily, will be available on global financial media, data terminals, and broker platforms from 1 July 2022.